Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8948538 | 0.92 | PDE4A (0.31) | PDE4A | |
| SCHEMBL9222926 | 0.86 | PTGES (0.31) | — | |
| SCHEMBL8948510 | 0.81 | — | — | |
| SCHEMBL6800796 | 0.80 | — | — | |
| SCHEMBL8924168 | 0.79 | MAOA (0.30) | — | |
| SCHEMBL9222964 | 0.79 | NPSR1 (0.30) | — | |
| SCHEMBL8196825 | 0.78 | — | — | |
| SCHEMBL8948528 | 0.77 | — | — | |
| SCHEMBL8821968 | 0.77 | — | — | |
| SCHEMBL8300937 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004072065-A1 | NOVEL OXYGEN CONTAINING FUSED CYCLIC DERIVATIVES AND HERBIDICAL, DESICCANT AND DEFOLIATE COMPOSITIONS CONTAINING THEM | ISHIHARA SANGYO KAISHA, LTD. (JP) | 2004-08-26 | — | — | WO | disclosed |
| US-20040157738-A1 | Novel oxygen containing fused cyclic derivatives and herbicidal, desiccant and defoliate compositions containing them | ISHIHARA SANGYO KAISHA, LTD. | 2004-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040157738-A1 | Novel oxygen containing fused cyclic derivatives and herbicidal, desiccant and defoliate compositions containing them | DDT, CBR3, DUOX2 | PDE4A 498/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.